Impact of microscopically positive resection margins (R1) on overall survival and recurrence rate in hepatoblastoma: A systematic review and meta-analysis

This meta-analysis suggests that R1 resection margins are not associated with significantly worse OS or EFS compared with R0 resections in hepatoblastoma. However, R0 resection should remain the surgical objective. In selected, e.g. locally advanced cases, minimal margins may be acceptable when vascular replacement or transplantation can be avoided, as current evidence suggests no significant adverse oncologic impact after neoadjuvant chemotherapy. Nevertheless, existing data are limited to retrospective cohorts, underscoring the need for prospective, histopathologically detailed studies.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Surgery
Published
2025-12-31
DOI
https://doi.org/10.1016/j.jpedsurg.2025.162910
Citations
1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of microscopically positive resection margins (R1) on overall survival and recurrence rate in hepatoblastoma: A systematic review and meta-analysis

Patrick Günther, Fabian Ruping, M. Keßler, Ida Reinhold et al.
1 citations
Journal of Pediatric Surgery
Hepatocellular Carcinoma Treatment and Prognosis
1.32
article

Impact of microscopically positive resection margins (R1) on overall survival and recurrence rate in hepatoblastoma: A systematic review and meta-analysis

Patrick Günther, Fabian Ruping, M. Keßler, Ida Reinhold, Philipp Romero, Juri Fuchs
article en
1 citations

Abstract

This meta-analysis suggests that R1 resection margins are not associated with significantly worse OS or EFS compared with R0 resections in hepatoblastoma. However, R0 resection should remain the surgical objective. In selected, e.g. locally advanced cases, minimal margins may be acceptable when vascular replacement or transplantation can be avoided, as current evidence suggests no significant adverse oncologic impact after neoadjuvant chemotherapy. Nevertheless, existing data are limited to retrospective cohorts, underscoring the need for prospective, histopathologically detailed studies.

Journal of Pediatric SurgeryVol. 61(3)
Heidelberg University (DE)
Good health and well-being
Openalex Percentile: Top 13%
Hepatocellular Carcinoma Treatment and Prognosis
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.